Strategic Financial Services Inc. Lowers Stake in SPDR S&P Biotech ETF $XBI

Strategic Financial Services Inc. lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 260,924 shares of the exchange traded fund’s stock after selling 24,213 shares during the period. SPDR S&P Biotech ETF accounts for 1.5% of Strategic Financial Services Inc.’s investment portfolio, making the stock its 16th largest holding. Strategic Financial Services Inc.’s holdings in SPDR S&P Biotech ETF were worth $32,749,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in XBI. Dynamic Wealth Strategies LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after buying an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after buying an additional 81 shares in the last quarter. Compass Ion Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 2.6% in the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after buying an additional 97 shares in the last quarter. Moors & Cabot Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after buying an additional 100 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 3.1% in the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock worth $340,000 after buying an additional 101 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $133.35 on Wednesday. SPDR S&P Biotech ETF has a one year low of $78.06 and a one year high of $139.19. The company’s fifty day moving average price is $130.23 and its 200-day moving average price is $125.49. The company has a market capitalization of $8.51 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.